FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to method for restoring normal tissue from fibrous tissue, which can be used in medicine. Subject gets an effective amount of a pharmaceutical composition comprising (a) collagen-reducing substance, (b) substance for targeted delivery of collagen-reducing substance to collagen-producing fibrous tissue cells, and stem cells are transplanted into space for stem cell growth and differentiation.
EFFECT: present invention allows efficient regeneration of normal tissue from fibrous tissue, where fibrous tissue continuously receives fibrous stimulus.
4 cl, 21 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING MYELOFIBROSIS | 2009 |
|
RU2557997C2 |
| AGENT FOR TREATING RENAL FIBROSIS | 2011 |
|
RU2711531C2 |
| MEANS FOR KIDNEY FIBROSIS TREATMENT | 2011 |
|
RU2635460C2 |
| LIPOSOMS WITH RETYNOID TO STRENGTHEN hsp47 EXPRESSION MODULATION | 2012 |
|
RU2628694C2 |
| MEANS FOR INTESTINAL FIBROSIS TREATMENT | 2012 |
|
RU2637372C2 |
| RADIX SALVIAE MILTIORRHIZAE (DAN SHEN) OR PREPARATIONS THEREOF APPLICATION FOR PREPARATION OF DRUGS FOR TREATMENT OF DISEASES RELATED TO LIVER FIBROSIS | 2013 |
|
RU2623147C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY FIBROUS DISEASES | 2010 |
|
RU2561672C2 |
| IMAGING AGENTS FOR FIBROUS DISEASES | 2009 |
|
RU2596495C2 |
| THERAPEUTIC AGENT APPLICABLE IN PULMONARY FIBROSIS | 2009 |
|
RU2547571C2 |
| THERAPEUTIC AGENT FOR PULMONARY FIBROSIS | 2015 |
|
RU2678968C2 |
